|
1）Sastre J. Molecular diagnosis in allergy. Clin Exp Allergy. 2010; 40: 1442-60
|
|
|
|
2）Alessandri C, Zennaro D, Scala E, et al. Ovomucoid （Gal d 1） specific IgE detected by microarray system predict tolerability to boiled hen’s egg and an increased risk to progress to multiple environmental allergen sensitisation. Clin Exp Allergy. 2012; 42: 441-50
|
|
|
|
|
|
3）Pedrosa M, Boyano-Martinez T, Garcia-Ara MC, et al. Peanut seed storage proteins are responsible for clinical reactivity in Spanish peanut-allergic children. Pediatr Allergy Immunol. 2012; 23: 654-9
|
|
|
|
|
|
4）Bonini M, Marcomini L, Gramiccioni C, et al. Microarray evaluation of specific IgE to allergen components in elite athletes. Allergy. 2012; 67: 1157-64
|
|
|
|
|
|
5）Bronnert M, Mancini J, Birnbaum J, et al. Component-resolved diagnosis with commercially available D. Pteronyssinus Der p 1, Der p 2, and Der p 10: relevant markers for house dust mite allergy. Clin Exp Allergy. 2012; 42: 1406-15
|
|
|
|
|
|
6）Cabrera-Freitag P, Goikoetxea MJ, Beorlegui C, et al. Can component-based microarray replace fluorescent enzimoimmunoassay in the diagnosis of grass and cypress pollen allergy? Clin Exp Allergy. 2011; 41: 1440-6
|
|
|
|
|
|
7）Canonica GW, Ansotegui IJ, Pawankar R, et al. A WAO - ARIA - GA（2）LEN consensus document on molecular-based allergy diagnostics. World Allergy Organ J. 2013; 6: 17
|
|
|
|
|
|
8）Kazemi-Shirazi L, Niederberger V, Linhart B, et al. Recombinant marker allergens: diagnostic gatekeepers for the treatment of allergy. Int Arch Allergy Immunol. 2002; 127: 259-68
|
|
|
|
|
|
9）Valenta R, Twaroch T, Swoboda I. Component-resolved diagnosis to optimize allergen-specific immunotherapy in the Mediterranean area. J Investig Allergol Clin Immunol. 2007; 17 Suppl 1: 36-40
|
|
|
|
|
|
10）Minami T, Fukutomi Y, Lidholm J, et al. IgE Abs to Der p 1 and Der p 2 as diagnostic markers of house dust mite allergy as defined by a bronchoprovocation test. Allergol Int. 2015; 64: 90-5
|
|
|
|
|
11）Greenberger PA. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol. 2002; 110: 685-92
|
|
|
|
|
|
12）O’Hollaren MT, Yunginger JW, Offord KP, et al. Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma. N Engl J Med. 1991; 324: 359-63
|
|
|
|
|
|
13）Fukutomi Y, Taniguchi M. Sensitization to fungal allergens: resolved and unresolved issues. Allergol Int. 2015; 64: 321-31
|
|
|
|
|
|
14）Tanimoto T, Fukutomi Y, Yasueda H. Molecular-based allergy diagnosis of allergic bronchopulmonary aspergillosis in Aspergillus fumigatus-sensitized Japanese patients. Clin Exp Allergy. in press
|
|
|
|
|
|
15）Vailes LD, Perzanowski MS, Wheatley LM, et al. IgE and IgG antibody responses to recombinant Alt a 1 as a marker of sensitization to Alternaria in asthma and atopic dermatitis. Clin Exp Allergy. 2001; 31: 1891-5
|
|
|
|
|